{"id":"NCT02696798","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-04-12","primaryCompletion":"2018-05-18","completion":"2019-05-03","firstPosted":"2016-03-02","resultsPosted":"2019-10-30","lastUpdate":"2020-06-17"},"enrollment":316,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Spondyloarthritis"],"interventions":[{"type":"DRUG","name":"Ixekizumab","otherNames":["LY2439821"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Q2W Ixekizumab","type":"EXPERIMENTAL"},{"label":"Q4W Ixekizumab","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The main purpose of this study is to evaluate the efficacy and safety of ixekizumab in tumor necrosis factor (TNF) inhibitor-experienced participants with radiographic axial spondyloarthritis (rad-axSpA).","primaryOutcome":{"measure":"Percentage of Participants Achieving an Assessment of Spondyloarthritis International Society 40 (ASAS40) Response","timeFrame":"Week 16","effectByArm":[{"arm":"Placebo","deltaMin":12.5,"sd":null},{"arm":"80 mg Q4W Ixekizumab","deltaMin":25.4,"sd":null},{"arm":"80 mg Q2W Ixekizumab","deltaMin":30.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.017"},{"comp":"OG000 vs OG002","p":"0.003"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":9},"locations":{"siteCount":99,"countries":["United States","Argentina","Brazil","Canada","Finland","France","Germany","Israel","Italy","Japan","Mexico","Netherlands","Poland","Puerto Rico","South Korea","Spain","United Kingdom"]},"refs":{"pmids":["40694276","36792107","36282526","35429281","35188180","34853086","34538257","31685553","31254223","30343531"],"seeAlso":["http://www.lillytrialguide.com/EN-us/studies/arthritis/rhbw"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":98},"commonTop":["Upper respiratory tract infection","Arthralgia","Nasopharyngitis","Injection site reaction","Back pain"]}}